Jana Grieb specializes in health care and life sciences, with a particular focus on the pharmaceutical and medtech industry.Jana has advised numerous pharmaceutical and medical devices companies in a variety of regulatory issues, transactions and contractual matters across the European Union, and has represented them in litigation with regard to public procurement law, unfair competition and reimbursement by public and private payers.
Prior to joining McDermott, Jana worked for an international law firm and a Munich-based law firm focusing on pharmaceutical law.
Counsel | Munich
Munich: +49 89 12712 322
Munich: +49 89 12712 117
Shanghai, China / McDermott Event / November 12, 2019
International News / Winter 2018
Shanghai, China / McDermott Event / December 5, 2018
Pharm. Ind. 80, Issue 10 / November 2018
Cambridge, Massachusetts / McDermott Event / September 12, 2018
Copenhagen, Denmark / Speaking Engagements / June 12, 2018
Washington, District of Columbia / Speaking Engagements / May 3-4, 2018
On the Subject / May 9, 2017
Cyber Security Law & Practice: Volume 2, Issue 4 / April 2016
The Chilling Ransomware Threat Facing Hospitals
Cyber Security Law & Practice (London) / April 2016
PharmaRecht, Issue 4 / April 30, 2015
Comparable Drugs in Price Negotiations Under Sec. 130b SGB V
International Law Office Newsletter, Germany / October 29, 2014
German Perspective on New EU Clinical Trials Regulation
On the Subject / October 20, 2014
VC Magazine / April 23, 2014
Legal Framework for Health Apps
eHealth Law & Policy, Volume 1, Issue 2 / March 2014
Germany Further Liberalises Pharma Advertising Online
Healthcare Marketing - Das Fachmagazin für Gesundheitsmarken, Issue 1-2 / January 2014
Patent Expirations: Generic Drugs and Active Ingredient Producers from the Perspective of ...
1
2
3
London / Press Releases / September 18, 2019
McDermott to Host European Healthcare Private Equity Leadership Forum 2019
London / Accolades & Rankings / March 18, 2019
Düsseldorf / Accolades & Rankings / March 9, 2018
McDermott Again Ranked as a Leading Law Firm By Chambers Europe
Munich / Global Legal Chronicle / July 31, 2017
Eurofins Scientific SE’s Acquisition of MVZ für Laboratoriumsmedizin of Hygel
Düsseldorf / Press Releases / May 8, 2017
Düsseldorf / Accolades & Rankings / April 10, 2017
Munich / Juve (Germany) / September 25, 2016
Paris / Press Releases / December 3, 2015
McDermott Advises Servier on Strategic Agreement with Cellectis
Le Monde du Droit (France) / November 25, 2015
JUVE (Germany) / June 29, 2015
Laboratory Services: Cinven Works with Clifford to Buy Synlab for 1.2 Billion Euros
Düsseldorf / Accolades & Rankings / May 5, 2015
McDermott European Practice Shows Continuous Growth in Ranking Results in Chambers Europe 2015
Munich / eHealth Law & Policy (Germany) / March 31, 2014
1
2
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.
